Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
87.40
+4.40 (5.30%)
Feb 21, 2025, 3:00 PM EST

Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of 391.83 billion. The enterprise value is 402.54 billion.

Market Cap 391.83B
Enterprise Value 402.54B

Important Dates

The last earnings date was Wednesday, February 5, 2025.

Earnings Date Feb 5, 2025
Ex-Dividend Date Aug 15, 2024

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -0.71%
Shares Change (QoQ) -0.11%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 3.18B

Valuation Ratios

The trailing PE ratio is 27.95.

PE Ratio 27.95
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 87.13
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.39, with an EV/FCF ratio of 39.29.

EV / Earnings 28.71
EV / Sales 9.89
EV / EBITDA 19.39
EV / EBIT 20.54
EV / FCF 39.29

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.72.

Current Ratio 0.74
Quick Ratio 0.52
Debt / Equity 0.72
Debt / EBITDA 0.69
Debt / FCF 1.39
Interest Coverage 85.29

Financial Efficiency

Return on equity (ROE) is 80.78% and return on invested capital (ROIC) is 46.03%.

Return on Equity (ROE) 80.78%
Return on Assets (ROA) 22.41%
Return on Invested Capital (ROIC) 46.03%
Return on Capital Employed (ROCE) 56.34%
Revenue Per Employee 524,749
Profits Per Employee 182,482
Employee Count 77,349
Asset Turnover 0.74
Inventory Turnover 1.20

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -28.15% in the last 52 weeks. The beta is 0.19, so Novo Nordisk's price volatility has been lower than the market average.

Beta (5Y) 0.19
52-Week Price Change -28.15%
50-Day Moving Average 88.56
200-Day Moving Average 117.52
Relative Strength Index (RSI) 55.26
Average Volume (20 Days) 118,943

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of 40.31 billion and earned 14.02 billion in profits. Earnings per share was 3.14.

Revenue 40.31B
Gross Profit 34.27B
Operating Income 19.42B
Pretax Income 17.66B
Net Income 14.02B
EBITDA 20.36B
EBIT 19.42B
Earnings Per Share (EPS) 3.14
Full Income Statement

Balance Sheet

The company has 3.65 billion in cash and 14.27 billion in debt, giving a net cash position of -10.62 billion.

Cash & Cash Equivalents 3.65B
Total Debt 14.27B
Net Cash -10.62B
Net Cash Per Share n/a
Equity (Book Value) 19.92B
Book Value Per Share 4.49
Working Capital -7.86B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.79 billion and capital expenditures -6.55 billion, giving a free cash flow of 10.25 billion.

Operating Cash Flow 16.79B
Capital Expenditures -6.55B
Free Cash Flow 10.25B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 85.00%, with operating and profit margins of 48.17% and 34.78%.

Gross Margin 85.00%
Operating Margin 48.17%
Pretax Margin 43.80%
Profit Margin 34.78%
EBITDA Margin 50.51%
EBIT Margin 48.17%
FCF Margin 25.41%

Dividends & Yields

This stock pays an annual dividend of 0.52, which amounts to a dividend yield of 0.59%.

Dividend Per Share 0.52
Dividend Yield 0.59%
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio 43.71%
Buyback Yield 0.71%
Shareholder Yield 1.29%
Earnings Yield 3.58%
FCF Yield 2.61%
Dividend Details

Stock Splits

The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.

Last Split Date Sep 13, 2023
Split Type Forward
Split Ratio 2

Scores

Novo Nordisk has an Altman Z-Score of 8.94.

Altman Z-Score 8.94
Piotroski F-Score n/a